529 research outputs found
Nonlocal multi-trace sources and bulk entanglement in holographic conformal field theories
We consider CFT states defined by adding nonlocal multi-trace sources to the
Euclidean path integral defining the vacuum state. For holographic theories, we
argue that these states correspond to states in the gravitational theory with a
good semiclassical description but with a more general structure of bulk
entanglement than states defined from single-trace sources. We show that at
leading order in large N, the entanglement entropies for any such state are
precisely the same as those of another state defined by appropriate
single-trace effective sources; thus, if the leading order entanglement
entropies are geometrical for the single-trace states of a CFT, they are
geometrical for all the multi-trace states as well. Next, we consider the
perturbative calculation of 1/N corrections to the CFT entanglement entropies,
demonstrating that these show qualitatively different features, including
non-analyticity in the sources and/or divergences in the naive perturbative
expansion. These features are consistent with the expectation that the 1/N
corrections include contributions from bulk entanglement on the gravity side.
Finally, we investigate the dynamical constraints on the bulk geometry and the
quantum state of the bulk fields which must be satisfied so that the entropies
can be reproduced via the quantum-corrected Ryu-Takayanagi formula.Comment: 60 pages + appendices, 7 figures; v2: minor additions, published
versio
Areas and entropies in BFSS/gravity duality
The BFSS matrix model provides an example of gauge-theory / gravity duality
where the gauge theory is a model of ordinary quantum mechanics with no spatial
subsystems. If there exists a general connection between areas and entropies in
this model similar to the Ryu-Takayanagi formula, the entropies must be more
general than the usual subsystem entanglement entropies. In this note, we first
investigate the extremal surfaces in the geometries dual to the BFSS model at
zero and finite temperature. We describe a method to associate regulated areas
to these surfaces and calculate the areas explicitly for a family of surfaces
preserving symmetry, both at zero and finite temperature. We then
discuss possible entropic quantities in the matrix model that could be dual to
these regulated areas.Comment: 29 pages, 3 figures. v2 Examples in section 6 moved to appendix.
Minor comments adde
Quantitative analysis of PiB-PET with FreeSurfer ROIs
In vivo quantification of β-amyloid deposition using positron emission tomography is emerging as an important procedure for the early diagnosis of the Alzheimer's disease and is likely to play an important role in upcoming clinical trials of disease modifying agents. However, many groups use manually defined regions, which are non-standard across imaging centers. Analyses often are limited to a handful of regions because of the labor-intensive nature of manual region drawing. In this study, we developed an automatic image quantification protocol based on FreeSurfer, an automated whole brain segmentation tool, for quantitative analysis of amyloid images. Standard manual tracing and FreeSurfer-based analyses were performed in 77 participants including 67 cognitively normal individuals and 10 individuals with early Alzheimer's disease. The manual and FreeSurfer approaches yielded nearly identical estimates of amyloid burden (intraclass correlation = 0.98) as assessed by the mean cortical binding potential. An MRI test-retest study demonstrated excellent reliability of FreeSurfer based regional amyloid burden measurements. The FreeSurfer-based analysis also revealed that the majority of cerebral cortical regions accumulate amyloid in parallel, with slope of accumulation being the primary difference between regions
Baseline microglial activation correlates with brain amyloidosis and longitudinal cognitive decline in Alzheimer disease
BACKGROUND AND OBJECTIVES: This study aims to quantify microglial activation in individuals with Alzheimer disease (AD) using the 18-kDa translocator protein (TSPO) PET imaging in the hippocampus and precuneus, the 2 AD-vulnerable regions, and to evaluate the association of baseline neuroinflammation with amyloidosis, tau, and longitudinal cognitive decline.
METHODS: Twenty-four participants from the Knight Alzheimer Disease Research Center (Knight ADRC) were enrolled and classified into stable cognitively normal, progressor, and symptomatic AD groups based on clinical dementia rating (CDR) at 2 or more clinical assessments. The baseline TSPO radiotracer [11C]PK11195 was used to image microglial activation. Baseline CSF concentrations of Aβ42, Aβ42/Aβ40 ratio, tau phosphorylated at position 181 (p-tau181), and total tau (t-tau) were measured. Clinical and cognitive decline were examined with longitudinal CDR and cognitive composite scores (Global and Knight ADRC-Preclinical Alzheimer Cognitive Composite [Knight ADRC-PACC] Score).
RESULTS: Participants in the progressor and symptomatic AD groups had significantly elevated [11C]PK11195 standard uptake value ratios (SUVRs) in the hippocampus but not in the precuneus region. In the subcohort with CSF biomarkers (16 of the 24), significant negative correlations between CSF Aβ42 or Aβ42/Aβ40 and [11C]PK11195 SUVR were observed in the hippocampus and precuneus. No correlations were observed between [11C]PK11195 SUVR and CSF p-tau181 or t-tau at baseline in those regions. Higher baseline [11C]PK11195 SUVR averaged in the whole cortical regions predicted longitudinal decline on cognitive tests.
DISCUSSION: Microglial activation is increased in individuals with brain amyloidosis and predicts worsening cognition in AD.
CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that in patients with AD, higher baseline [11C]PK11195 SUVR averaged in the whole cortical regions was associated with longitudinal decline on cognitive tests
Recommended from our members
Florbetapir F 18 amyloid PET and 36-month cognitive decline:a prospective multicenter study
This study was designed to evaluate whether subjects with amyloid beta (Aβ) pathology, detected using florbetapir positron emission tomorgraphy (PET), demonstrated greater cognitive decline than subjects without Aβ pathology. Sixty-nine cognitively normal (CN) controls, 52 with recently diagnosed mild cognitive impairment (MCI) and 31 with probable Alzheimer's disease (AD) dementia were included in the study. PET images obtained in these subjects were visually rated as positive (Aβ+) or negative (Aβ−), blind to diagnosis. Fourteen percent (10/69) of CN, 37% (19/52) of MCI and 68% (21/31) of AD were Aβ+. The primary outcome was change in ADAS-Cog score in MCI subjects after 36 months; however, additional outcomes included change on measures of cognition, function and diagnostic status. Aβ+ MCI subjects demonstrated greater worsening compared with Aβ− subjects on the ADAS-Cog over 36 months (5.66±1.47 vs −0.71±1.09, P=0.0014) as well as on the mini-mental state exam (MMSE), digit symbol substitution (DSS) test, and a verbal fluency test (P<0.05). Similar to MCI subjects, Aβ+ CN subjects showed greater decline on the ADAS-Cog, digit-symbol-substitution test and verbal fluency (P<0.05), whereas Aβ+ AD patients showed greater declines in verbal fluency and the MMSE (P<0.05). Aβ+ subjects in all diagnostic groups also showed greater decline on the CDR-SB (P<0.04), a global clinical assessment. Aβ+ subjects did not show significantly greater declines on the ADCS-ADL or Wechsler Memory Scale. Overall, these findings suggest that in CN, MCI and AD subjects, florbetapir PET Aβ+ subjects show greater cognitive and global deterioration over a 3-year follow-up than Aβ− subjects do
- …